Variant report
Variant | esv3335405 |
---|---|
Chromosome Location | chr7:25952027-25957925 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:12)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:25953417..25956574-chr7:25956816..25958986,3 | K562 | blood: | |
2 | chr7:25952760..25954350-chr7:25989892..25992459,2 | K562 | blood: | |
3 | chr7:25957300..25959030-chr7:25962063..25963663,2 | K562 | blood: | |
4 | chr7:25953417..25956574-chr7:25956816..25958986,3 | K562 | blood: | |
5 | chr7:25945944..25949352-chr7:25952890..25956249,3 | K562 | blood: | |
6 | chr7:25951761..25954301-chr7:25955660..25959203,4 | K562 | blood: | |
7 | chr7:25953157..25955239-chr7:25965807..25967682,2 | K562 | blood: | |
8 | chr7:25939345..25941497-chr7:25950960..25952710,2 | K562 | blood: | |
9 | chr7:25956397..25958316-chr7:25961435..25964267,2 | K562 | blood: | |
10 | chr7:25951761..25954301-chr7:25955660..25959203,4 | K562 | blood: | |
11 | chr7:25951352..25952965-chr7:25956982..25959003,2 | K562 | blood: | |
12 | chr7:25951352..25952965-chr7:25956982..25959003,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-HNRNPA2B1-11 | chr7:25955640-25955975 | expReg_chr7_2066_- |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556906610 | chr7:25953210-25953211 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs80272835 | chr7:25953254-25953255 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566641907 | chr7:25953259-25953260 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146674685 | chr7:25953326-25953327 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568764087 | chr7:25953377-25953378 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs567209824 | chr7:25953398-25953399 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575231809 | chr7:25953415-25953416 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536158641 | chr7:25953449-25953450 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557297536 | chr7:25953484-25953485 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577589785 | chr7:25953490-25953491 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182271322 | chr7:25953499-25953500 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs140241634 | chr7:25953507-25953508 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143974252 | chr7:25953524-25953525 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35930157 | chr7:25953532-25953533 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542491287 | chr7:25953563-25953564 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562272754 | chr7:25953585-25953586 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146454630 | chr7:25953594-25953595 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187221652 | chr7:25953678-25953679 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs4722543 | chr7:25953720-25953721 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs533204768 | chr7:25953743-25953744 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572511098 | chr7:25953756-25953757 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547060316 | chr7:25953806-25953807 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566897467 | chr7:25953807-25953808 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529391012 | chr7:25953809-25953810 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544642959 | chr7:25953825-25953826 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191633774 | chr7:25953835-25953836 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185384108 | chr7:25953985-25953986 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557659427 | chr7:25954000-25954001 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557617444 | chr7:25954009-25954010 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571207664 | chr7:25954018-25954019 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533594734 | chr7:25954042-25954043 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs140755180 | chr7:25954045-25954046 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573610399 | chr7:25954067-25954068 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs373332764 | chr7:25954086-25954087 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558614826 | chr7:25954099-25954100 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188249070 | chr7:25954139-25954140 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575269958 | chr7:25954140-25954141 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs36118653 | chr7:25954144-25954145 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576168045 | chr7:25955642-25955643 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs564405909 | chr7:25955665-25955666 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs139560080 | chr7:25955671-25955672 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs374666691 | chr7:25955720-25955721 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs188559037 | chr7:25955727-25955728 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs12154905 | chr7:25955754-25955755 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs141705591 | chr7:25955863-25955864 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs530014674 | chr7:25955888-25955889 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs58300964 | chr7:25955932-25955933 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs62446262 | chr7:25955946-25955947 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs569654047 | chr7:25955949-25955950 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs368004984 | chr7:25955958-25955959 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Cancer | 21183584 | CNVD |
abnormal development | 18461090 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Lung cancer | 17086460 | CNVD |
Breast cancer | 18852474 | CNVD |
Acute myeloid leukemia | 20962326 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:25953200-25954200 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr7:25953200-25954200 | Enhancers | Fetal Lung | lung |
3 | chr7:25953600-25953800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr7:25957200-25957800 | Active TSS | Aorta | Aorta |